Overview

A Clinical Trial of YMC017 in Hypertensive and Hypercholesterolemic Patients With Metabolic Syndrome

Status:
Terminated
Trial end date:
2018-02-01
Target enrollment:
Participant gender:
Summary
This is a Randomized, open-label, 2 groups, parallel design.
Phase:
Phase 4
Details
Lead Sponsor:
Yuhan Corporation
Collaborator:
Linical Korea
Treatments:
Rosuvastatin Calcium
Telmisartan